Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Sven Kohler · SciRah

Researcher profile · Semantic Scholar

Sven Kohler

Share profile

Sven Kohler — researcher profile on SciRah

h-index: 8
Works: 11
Citations: 549

Most-cited papers

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Sven Kohler, C. Zeller, H. Iliev, S. Kaspers
2017Advances in Therapy180 citations Open access
Semantic Scholar
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
B. Zinman, S. Inzucchi, J. Lachin, C. Wanner +8 more
2017Stroke118 citations Open access
Semantic Scholar
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes.
Sven Kohler, Afshin Salsali, S. Hantel, S. Kaspers +3 more
2016Clinical Therapeutics88 citations Open access
Semantic Scholar
Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride
Sven Kohler, S. Kaspers, Afshin Salsali, C. Zeller +1 more
2018Diabetes Care57 citations
Semantic Scholar
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–III clinical trials
D. Yabe, A. Yasui, L. Ji, Moon-Kyu Lee +8 more
2018Journal of Diabetes Investigation41 citations Open access
Semantic Scholar
Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
R. Nishimura, Yuko Tanaka, Kazuki Koiwai, Kosuke Ishida +4 more
2019Advances in Therapy29 citations
Semantic Scholar
Bladder cancer in the EMPA-REG OUTCOME trial
Sven Kohler, Jisoo Lee, J. George, S. Inzucchi +1 more
2017Diabetologia25 citations Open access
Semantic Scholar
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
R. DeFronzo, Christopher Lee, Sven Kohler
2018Advances in Therapy10 citations Open access
Semantic Scholar
Effect of empagliflozin on diabetic ketoacidosis in patients with type 2 diabetes: pooled clinical trial data
S. Lund, F. Solimando, Sven Kohler, C. Zeller +1 more
2017Diabetologie und Stoffwechsel2 citations
Semantic Scholar
Safety and tolerability of combinations of empagliflozin/linagliptin for 52 weeks in patients with type 2 diabetes
Sanjay R. Patel, R. DeFronzo, A. Lewin, Renee Kaste +3 more
20161 citations
Semantic Scholar
Efficacy and safety of empagliflozin by baseline age in patients with type 2 diabetes
M. Roden, S. Lund, E. Pfarr, Sven Kohler +2 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Kaspers×5
Invite
S. Kaspers — researcher profile on SciRah
C. Zeller×4
Invite
C. Zeller — researcher profile on SciRah
H. Woerle×3
Invite
H. Woerle — researcher profile on SciRah
Uli C. Broedl×3
Invite
Uli C. Broedl — researcher profile on SciRah

×3

Invite

Afshin Salsali — researcher profile on SciRah

Invite

B. Zinman — researcher profile on SciRah

Invite

S. Inzucchi — researcher profile on SciRah

Invite

Jisoo Lee — researcher profile on SciRah

Invite

S. Lund — researcher profile on SciRah

Invite

R. DeFronzo — researcher profile on SciRah

Invite

H. Iliev — researcher profile on SciRah

Invite

J. Lachin — researcher profile on SciRah